March’s Top Biopharma Headlines
March 31, 2022
Here are some of the top news stories that we noted in March, including company news, approvals, research, and more
1 min read

March 31, 2022
Here are some of the top news stories that we noted in March, including company news, approvals, research, and more
1 min read
March 30, 2022
How Avatour is digitally transforming audits and inspections for the pharma industry
1 min read
March 29, 2022
With the FDA still behind on inspections, manufacturers need to uncover their own blindspots
1 min read
March 28, 2022
How therapeutics are expanding into a whole new galaxy of options
1 min read
March 25, 2022
Why modular or mobile is the best way to go for CMOs
1 min read
March 24, 2022
That which we call rosaimab by any other name would find regulatory approval and commercial success. Or would it?
1 min read
March 24, 2022
Our eBook features mRNA vs malaria, vaccines for COVID-19, top tips for mRNA sequencing, and more
1 min read
March 23, 2022
How can smaller companies navigate scale up and complexity in microbial biomanufacturing?
1 min read
March 22, 2022
What is going on with Aduhelm?
1 min read
March 21, 2022
A microfluidics-based separation technology aims to overcome common issues in biomanufacturing
1 min read
False
False